Literature DB >> 18632830

Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer.

Corinna von Forstner1, Jan-Hendrik Egberts, Ole Ammerpohl, Dagmara Niedzielska, Ralph Buchert, Pal Mikecz, Udo Schumacher, Kersten Peldschus, Gerhard Adam, Christian Pilarsky, Robert Grutzmann, Holger Kalthoff, Eberhard Henze, Winfried Brenner.   

Abstract

UNLABELLED: Our aim was to use PET/MRI to evaluate and compare the uptake of 18F-FDG, 3-deoxy-3-18F-fluorothymidine (18F-FLT), and 18F-fluorethylcholine (18F-FEC) in human pancreatic tumor cell lines after xenotransplantation into SCID mice and to correlate tumor uptake with gene expression of membrane transporters and rate-limiting enzymes for tracer uptake and tracer retention.
METHODS: Four weeks after orthotopic inoculation of human pancreatic carcinoma cells (PancTuI, Colo357, and BxPC3) into SCID mice, combined imaging was performed with a small-animal PET scanner and a 3-T MRI scanner using a dedicated mouse coil. Tumor-to-liver uptake ratios (TLRs) of the tracers were compared with gene expression profiles of the tumor cell lines and both normal pancreatic tissue and pancreatic tumor tissue based on gene microarray analysis and quantitative polymerase chain reaction.
RESULTS: 18F-FLT showed the highest tumor uptake, with a mean TLR of 2.3, allowing correct visualization of all 12 pancreatic tumors. 18F-FDG detected only 4 of 8 tumors and had low uptake in tumors, with a mean TLR of 1.1 in visible tumors. 18F-FEC did not show any tumor uptake. Gene array analysis revealed that both hexokinase 1 as the rate-limiting enzyme for 18F-FDG trapping and pancreas-specific glucose transporter 2 were significantly downregulated whereas thymidine kinase 1, responsible for 18F-FLT trapping, was significantly upregulated in the tumor cell lines, compared with normal pancreatic duct cells and pancreatic tumor tissue. Relevant genes involved in the uptake of 18F-FEC were predominantly unaffected or downregulated in the tumor cell lines.
CONCLUSION: In comparison to 18F-FDG and 18F-FEC, 18F-FLT was the PET tracer with the highest and most consistent uptake in various human pancreatic tumor cell lines in SCID mice. The imaging results could be explained by gene expression patterns of membrane transporters and enzymes for tracer uptake and retention as measured by gene array analysis and quantitative polymerase chain reaction in the respective cell lines. Thus, standard molecular techniques provided the basis to help explain model-specific tracer uptake patterns in xenotransplanted human tumor cell lines in mice as observed by PET.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632830     DOI: 10.2967/jnumed.107.050021

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

1.  Fluorine-18-Labeled Thymidine Positron Emission Tomography (FLT-PET) as an Index of Cell Proliferation after Pharmacological Ascorbate-Based Therapy.

Authors:  John A Cieslak; Zita A Sibenaller; Susan A Walsh; Laura L Boles Ponto; Juan Du; John J Sunderland; Joseph J Cullen
Journal:  Radiat Res       Date:  2015-12-31       Impact factor: 2.841

Review 2.  Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer.

Authors:  Xiao-Yi Wang; Feng Yang; Chen Jin; De-Liang Fu
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 3.  Molecular imaging: current status and emerging strategies.

Authors:  M A Pysz; S S Gambhir; J K Willmann
Journal:  Clin Radiol       Date:  2010-07       Impact factor: 2.350

4.  High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells.

Authors:  Meredith C Henderson; Irma M Gonzales; Shilpi Arora; Ashish Choudhary; Jeffrey M Trent; Daniel D Von Hoff; Spyro Mousses; David O Azorsa
Journal:  Mol Cancer Res       Date:  2011-05-02       Impact factor: 5.852

5.  State-of-the-art PET/CT of the pancreas: current role and emerging indications.

Authors:  Dushyant V Sahani; Pietro A Bonaffini; Onofrio A Catalano; Alexander R Guimaraes; Michael A Blake
Journal:  Radiographics       Date:  2012 Jul-Aug       Impact factor: 5.333

6.  Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma.

Authors:  Neale S Mason; Brian J Lopresti; James Ruszkiewicz; Xinxin Dong; Sonali Joyce; George Leef; Malabika Sen; Abdus S Wahed; Chester A Mathis; Jennifer R Grandis; Sufi M Thomas
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-01-05

7.  Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation.

Authors:  Feng Cao; Zibo Li; Andrew Lee; Zhaofei Liu; Kai Chen; Hui Wang; Weibo Cai; Xiaoyuan Chen; Joseph C Wu
Journal:  Cancer Res       Date:  2009-03-24       Impact factor: 12.701

Review 8.  Glucose metabolic phenotype of pancreatic cancer.

Authors:  Anthony K C Chan; Jason I E Bruce; Ajith K Siriwardena
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

9.  FDG PET imaging of Ela1-myc mice reveals major biological differences between pancreatic acinar and ductal tumours.

Authors:  Ibane Abasolo; Judit Pujal; Rosa M Rabanal; Anna Serafin; Pilar Navarro; Olga Millán; Francisco X Real
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-28       Impact factor: 9.236

10.  Mass action models versus the Hill model: an analysis of tetrameric human thymidine kinase 1 positive cooperativity.

Authors:  Tomas Radivoyevitch
Journal:  Biol Direct       Date:  2009-12-09       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.